Q2727901 (Q2727901): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Edited by the materialized bot - inferring region from the coordinates) |
(Created claim: summary (P836): The project aims to strengthen the global competitiveness of Genera d.d. through the development and placement of innovative veterinary medicinal products — new alive (attenuated) lyophilised vaccines of four vaccine vaccinated strains, for the combined use and synergistic effect of infective bronchitis and contagious animal exchange diseases, as well as by strengthening the company’s research and development research and development capacity.,...) |
||||||||||||||
| Property / summary | |||||||||||||||
The project aims to strengthen the global competitiveness of Genera d.d. through the development and placement of innovative veterinary medicinal products — new alive (attenuated) lyophilised vaccines of four vaccine vaccinated strains, for the combined use and synergistic effect of infective bronchitis and contagious animal exchange diseases, as well as by strengthening the company’s research and development research and development capacity. (English) | |||||||||||||||
| Property / summary: The project aims to strengthen the global competitiveness of Genera d.d. through the development and placement of innovative veterinary medicinal products — new alive (attenuated) lyophilised vaccines of four vaccine vaccinated strains, for the combined use and synergistic effect of infective bronchitis and contagious animal exchange diseases, as well as by strengthening the company’s research and development research and development capacity. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: The project aims to strengthen the global competitiveness of Genera d.d. through the development and placement of innovative veterinary medicinal products — new alive (attenuated) lyophilised vaccines of four vaccine vaccinated strains, for the combined use and synergistic effect of infective bronchitis and contagious animal exchange diseases, as well as by strengthening the company’s research and development research and development capacity. (English) / qualifier | |||||||||||||||
point in time: 3 June 2021
| |||||||||||||||
Revision as of 09:45, 3 June 2021
Project Q2727901 in Croatia
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project Q2727901 in Croatia |
Statements
11,658,803.09 Croatian kuna
0 references
28,223,776.27 Croatian kuna
0 references
85.0 percent
0 references
19 April 2018
0 references
12 June 2021
0 references
Genera dioničko društvo za razvoj i proizvodnju farmaceutskih proizvoda
0 references
45°47'48.26"N, 15°46'34.64"E
0 references
10431
0 references
Svrha projekta je podići globalnu konkurentnost Genera d.d. razvojem i plasmanom inovativnog veterinarsko-medicinskog proizvoda - novog programa živih (atenuiranih) liofiliziranih cjepiva od četiri cjepna soja, za kombiniranu primjenu i sinergistički efekt prlikom tretiranja infektivnog bronhitisa i zarazne bolesti burze u peradi, kao i jačanjem istraživačko-razvojnih kapaciteta tvrtke. (Croatian)
0 references
The project aims to strengthen the global competitiveness of Genera d.d. through the development and placement of innovative veterinary medicinal products — new alive (attenuated) lyophilised vaccines of four vaccine vaccinated strains, for the combined use and synergistic effect of infective bronchitis and contagious animal exchange diseases, as well as by strengthening the company’s research and development research and development capacity. (English)
3 June 2021
0 references
Identifiers
KK.01.2.1.01.0092
0 references